Industry Ranks Well On Pediatric Trial Completion But Not Publication
Executive Summary
Compared to academic-funded pediatric studies, industry-backed studies more likely to be completed, Boston researchers conclude.
You may also be interested in...
Pediatric Study Compliance Could Face Scrutiny In PDUFA Renewal
FDA says compliance is on par with other postmarketing requirements, but jury is still out on whether public posting of noncompliance letters has been effective tool to ensure timely trial completion.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.